(Q39404079)

11 September 2017

Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial (English)

1 reference

11 September 2017

0 references

0 references

0 references

12

1 reference

11 September 2017

Ana Luiza Bierrenbach

Ana Luiza Bierrenbach

11

0 references

Sergio S Cunha

Sergio S Cunha

3

0 references

Ines Dourado

Ines Dourado

8

0 references

Laura C Rodrigues

Laura C Rodrigues

1

0 references

author name string

Susan M Pereira

2

1 reference

11 September 2017

Bernd Genser

4

1 reference

11 September 2017

Maria Yury Ichihara

5

1 reference

11 September 2017

Silvana C de Brito

6

1 reference

11 September 2017

Miguel A Hijjar

7

1 reference

11 September 2017

Alvaro A Cruz

9

1 reference

11 September 2017

Clemax Sant'Anna

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

31 August 2005

1 reference

11 September 2017

1 reference

11 September 2017

366

1 reference

11 September 2017

9493

1 reference

11 September 2017

1290-1295

1 reference

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Modern vaccines. Mycobacterial diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Is Bacillus Calmette-Guerin revaccination necessary for Japanese children?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

A cost-benefit analysis of BCG revaccination in the Czech Republic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Recent progress in the development and testing of vaccines against human tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Correlates of protective immunity to Mycobacterium tuberculosis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Design of the Brazilian BCG-REVAC trial against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

BCG (Bacille of Calmette-Guérin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

The design and analysis of paired cluster randomized trials: an application of meta-analysis techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

[Prevalence and intensity of infection by intestinal parasites in school-aged children in the City of Salvador (Bahia, Brazil)]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Development of new vaccines and diagnostic reagents against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

New vaccines for the prevention of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

Ethical issues in tuberculosis vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967145-0

7 January 2021

10.1016/S0140-6736(05)67145-0

Identifiers

DOI

1 reference

11 September 2017

1 reference